Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Arrowhead Pharmaceuticals raises $700 million in convertible notes
January 12, 2026 5:05 PM ESTArrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) issued $700 million in convertible senior notes due 2032 on January 12, 2026, according to a company statement. The notes carry a 0.00% interest rate and do not accrete in principal amount.
J.P. Morgan Securities LLC and Jefferies LLC served as underwriters for the offering. The underwriters exercised their full over-allotment option to... More



